Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II-IIIA”

1,405 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,405 results

Large-scale testing (Phase 3)Study completedNCT03324802
What this trial is testing

Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After Surgery

Who this might be right for
Stage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7Stage IB Breast Cancer AJCC v7+4 more
Mayo Clinic 107
Testing effectiveness (Phase 2)Ended earlyNCT03735095
What this trial is testing

Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer

Who this might be right for
Locally Advanced Lung CarcinomaNon-Small Cell Lung CarcinomaSmall Cell Lung Carcinoma+5 more
Roswell Park Cancer Institute 19
Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Testing effectiveness (Phase 2)Looking for participantsNCT04789681
What this trial is testing

Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial

Who this might be right for
Lung CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8+10 more
M.D. Anderson Cancer Center 50
Not applicableEnded earlyNCT00104728
What this trial is testing

Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates

Who this might be right for
Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 42
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)WithdrawnNCT00057993
What this trial is testing

Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
Northwestern University
Not applicableStudy completedNCT00068328
What this trial is testing

Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer

Who this might be right for
Breast CancerPsychosocial Effects of Cancer and Its Treatment
Alliance for Clinical Trials in Oncology 1,706
Testing effectiveness (Phase 2)Study completedNCT00003992
What this trial is testing

Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 200
Testing effectiveness (Phase 2)Ended earlyNCT00505492
What this trial is testing

Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy

Who this might be right for
Uterine Neoplasms
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)UnknownNCT03903887
What this trial is testing

Anti-PD1 Antibody-activated TILs in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 20
Not applicableLooking for participantsNCT04723095
What this trial is testing

Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix

Who this might be right for
Cervical Large Cell Neuroendocrine CarcinomaCervical Neuroendocrine CarcinomaCervical Small Cell Carcinoma+19 more
M.D. Anderson Cancer Center 750
Testing effectiveness (Phase 2)Study completedNCT02434081
What this trial is testing

NIvolumab COmbination With Standard First-line Chemotherapy and Radiotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Carcinoma

Who this might be right for
Non-small Cell Lung Cancer Stage III
ETOP IBCSG Partners Foundation 94
Testing effectiveness (Phase 2)Study completedNCT03188393
What this trial is testing

Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery

Who this might be right for
Invasive Breast CarcinomaStage II Breast CancerStage IIA Breast Cancer+2 more
NRG Oncology 105
Testing effectiveness (Phase 2)Looking for participantsNCT05798845
What this trial is testing

The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer

Who this might be right for
NSCLC
Shanghai Chest Hospital 124
Testing effectiveness (Phase 2)Study completedNCT00955175
What this trial is testing

Hypofractionated 3-Dimensional Radiation Therapy in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer. ICORG 99-09

Who this might be right for
Lung Cancer
Cancer Trials Ireland 60
Not applicableStudy completedNCT03505736
What this trial is testing

Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+18 more
Wake Forest University Health Sciences 25
Not applicableTemporarily pausedNCT04981834
What this trial is testing

Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer

Who this might be right for
Stage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8+6 more
University of Southern California 196
Testing effectiveness (Phase 2)Ended earlyNCT04216472
What this trial is testing

Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+19 more
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT02154399
What this trial is testing

EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung Cancer

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+3 more
National Cancer Institute (NCI) 28
Load More Results